Praxis Precision Medicines Inc (NAS:PRAX)
$ 41.7 1.59 (3.96%) Market Cap: 713.40 Mil Enterprise Value: 508.21 Mil PE Ratio: 0 PB Ratio: 2.41 GF Score: 37/100

Praxis Precision Medicines Inc Epilepsy Day Transcript

Apr 27, 2022 / 12:30PM GMT
Release Date Price: $124.8 (+1.71%)
Marcio Souza
Praxis Precision Medicines, Inc. - President, CEO & Director

Good morning, and welcome, everyone. Thanks for being here in New York City with us and in the webcast. It's a really -- real honor and a privilege to have all of you here for our second Analyst Day, our Epilepsy Day today. As you can guess, we're going to be making some forward-looking statements. I'm not going to be reading out the text here, but I do encourage every and each one of you to look into our SEC filings, especially our Form 10-K filed with EDGAR.

So why are we here today, right? We're going to be talking mostly about the epilepsy franchise, but it would be disingenuous not to talk about the other 2 franchise, like each one of them have significant value creation for patients, first and foremost, it should starts and ends with who we are serving as a company, as a community, as investors.

The second is there's a number of real big events for Praxis coming up. And that was the disingenuous part, I'm just not addressing that upfront. I'm incredibly excited and all the team at Praxis and everyone

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot